Early treatments for COVID-19
The 5,680 treatments below have been reported as potentially beneficial for COVID-19. We currently review studies for:
acetaminophen
adintrevimab
alkalinization
antiandrogens
aspirin
bamlanivimab/etesevimab
bebtelovimab
bromhexine
budesonide
cannabidiol
casirivimab/imdevimab
cetylpyridinium chloride
chlorhexidine
colchicine
convalescent plasma
curcumin
diet
ensitrelvir
ensovibep
exercise
famotidine
favipiravir
fluvoxamine
HCQ
hydrogen peroxide
ibuprofen
indomethacin
iota-carrageenan
ivermectin
lactoferrin
melatonin
metformin
molnupiravir
N-acetylcysteine
nigella sativa
nitazoxanide
nitric oxide
paxlovid
peginterferon lambda
phthalocyanine
povidone-iodine
probiotics
proxalutamide
quercetin
remdesivir
selenium
sleep
sotrovimab
spironolactone
sunlight
tixagevimab/cilgavimab
vitamin A
vitamin B9
vitamin C
vitamin D
zinc
The following papers report potential benefits of 5,624
other treatments. We have not reviewed these studies.
Sort by number of studies
Sort alphabetically
Submit updates
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.